Epidiolex (cannabidiol) is the first FDA-approved drug that contains a purified drug substance derived from marijuana known as cannabidiol (CBD). However, unlike tetrahydrocannabinol (THC), which is the psychoactive component of marijuana, CBD does not cause intoxication or a 'high'. The FDA approved Epidiolex in June 2018 as an oral solution for patients two years and older to treat seizures linked with two rare and severe forms of epilepsy that start in childhood, Lennox-Gastaut syndrome and Dravet syndrome.
Subscribe to receive email notifications whenever new articles are published.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Nov 1st, 2018), Cerner Multum™ (updated Nov 1st, 2018), Wolters Kluwer™ (updated Oct 31st, 2018) and others. To view content sources and attributions, please refer to our editorial policy.